Research Articles Emergency management and asthma risk in young Medicaid-enrolled children with recurrent wheeze Isabel J. Hardee, MD, Isabella Zaniletti, PhD, MA, Melisa S. Tanverdi, MD, Andrew H. Liu, MD, Rakesh D. Mistry, MD, MS & Nidhya Navanandan, MD, MSCS Pages: 1-8 | DOI: 10.1080/02770903.2024.2314623 Evaluating the implementation of a community health worker-delivered intervention integrating asthma care in West Philadelphia public schools Kayla Clark,, MPH, Elizabeth Messineo,, MD, MPH, Tyra Bryant-Stephens,, MD, Angela Song,, MD, MPH, Darby Marx,, BA, Adina Lieberman,, MPH, Rinad S. Beidas,, PhD & Courtney Benjamin Wolk,, PhD Pages: 1-11 | DOI: 10.1080/02770903.2024.2313146 Biologics for asthma and risk of pneumonia Maria Gabriella Matera, MD, PhD, Josuel Ora, MD, Luigino Calzetta, DVM, PGDip, MPhil, PhD, Paola Rogliani, MD & Mario Cazzola, MD Pages: 1-7 | DOI: 10.1080/02770903.2024.2311236 Atomized inhalation of Icaritin reduces airway inflammation and remodeling in asthmatic mice Yintong He, MSc, Jian Cui, MSc, Bo Xiao, MSc, Lixia Hou, MSc, Zhimei Li, MSc, Huiqin Zuo, MSc, Yutong He, PhD & Dong Yao, PhD Pages: 1-10 | DOI: 10.1080/02770903.2024.2313131 Anti-IL-5 and anti-IL-5R biologics for severe asthma. Are there any differences in their effects? Paula Granda, PD, Elena Villamañán, PD, PhD, Carlos Carpio, MD, PhD, Daniel Laorden, MD, PhD, Santiago Quirce, MD, PhD, Rodolfo Álvarez-Sala, MD, PhD & on behalf of the NEUMO Study Group Pages: 1-10 | DOI: 10.1080/02770903.2024.2308684 Correlation between changes in serum YKL-40, LXRs, PPM1A, and TGF-β1 levels and airway remodeling and lung function in patients with bronchial asthma Ying Zhu, MS, Bowen Huang, PhD & Guang Jiang, MS Pages: 1-9 | DOI: 10.1080/02770903.2023.2301426 Activation of Notch1-GATA3 pathway in asthma bronchial epithelial cells induced by acute PM2.5 exposure and the potential protective role of microRNA-139-5p Junjun Huang, Yan Hu, Yunxia Wang & Zhou Jin Pages: 1-13 | DOI: 10.1080/02770903.2024.2316711This is the author accepted version which has not been proofed or edited Digitally monitored inhaled therapy: A ‘Smart’ way to manage severe asthma? Dominic L Sykes, Yee Yong See, Evon C Y Chow, Michael G Crooks, Helena Cummings, Mandy Robinson, Karen Watkins, Joanne Thompson, Kylie Overton, Charlotte Riches & Shoaib Faruqi Pages: 1-12 | DOI: 10.1080/02770903.2024.2316726This is the author accepted version which has not been proofed or edited Case Report Rapidly progressive mucus plugs in allergic bronchopulmonary mycosis Osamu Miyazaki,, MD, Akira Igarashi,, MD., PhD, Kento Sato,, MD, PhD, Sumito Inoue,, MD, PhD, Ryuto Yokoyama,, MD, Masaki Nakane,, MD, PhD, Sahoko Kodama,, MD, Ryo Hasegawa,, MD, Shigeharu Ueki,, MD, PhD, Takashi Yaguchi,, PhD, Akira Watanabe,, MD, PhD & Masafumi Watanabe,, MD, PhD Pages: 1-6 | DOI: 10.1080/02770903.2024.2312429 |
Recent Posts
- Quick Take: Depemokimab in Severe Asthma
- Analysis of the correlations and inconsistencies between spirometry and impulse oscillometry in the diagnosis of small-airway dysfunction
- Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care
- Cost-related non-adherence to medications among adults with asthma in the USA, 2011–2022
- Allergen Immunotherapy: Optimal Duration for Respiratory Allergy